| Description |
SP110 nuclear body protein |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
| Image |
No pdb structure |
No pdb structure |
| Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
|
|
| Drugs |
|
|
| Diseases |
|
|
| GWAS |
- B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy) ( 28112199)
- Cholangiocarcinoma in primary sclerosing cholangitis (time to event) ( 28779025)
- Chronic lymphocytic leukemia ( 18758461 28165464 24292274)
- Crohn's disease ( 28067908)
- Inflammatory bowel disease ( 28067908)
- Obesity-related traits ( 23251661)
- Subcutaneous adipose tissue ( 26480920)
|
- Adult body size ( 32376654)
- Aspartate aminotransferase levels in non-alcoholic fatty liver disease ( 31311600)
- Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes ( 29221444)
- Craniofacial microsomia ( 26853712)
- Mean corpuscular hemoglobin ( 29403010)
- Mean corpuscular volume ( 29403010)
- Menarche (age at onset) ( 23667675)
- Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks) ( 28437668)
|
| Interacting Genes |
11 interacting genes:
ANXA7
CDKN1A
NAP1L2
NDUFV2
OSGEP
RUNX3
SMN1
TK1
TSC22D1
TTR
ZSCAN9
|
14 interacting genes:
APP
ARF1
ARF6
CDC42
GRB7
GUCY1A1
GUCY1B1
RAC1
RHOA
RSPH14
SMN1
SRC
TK1
ZNF534
|
| Entrez ID |
3431 |
116987 |
| HPRD ID |
06832 |
16359 |
| Ensembl ID |
ENSG00000135899
|
ENSG00000157985
|
| Uniprot IDs |
Q9HB58
|
B2RZG9
Q9UPQ3
X5D293
|
| PDB IDs |
|
|
| Enriched GO Terms of Interacting Partners? |
|
|
| Tagcloud ? |
|
|
| Tagcloud (Difference) ? |
|
|
| Tagcloud (Intersection) ? |
|